WASHINGTON, D.C. – Today, Senator Tammy Baldwin (D-WI) called on the four biggest inhaler companies to stop unfairly locking out generics from the market and driving up the cost of inhalers for Americans. Specifically, in letters to AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline (GSK), and Teva, Senator Baldwin called on the companies to stop improperly listing patents for inhalers in the...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
